Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Summary Comparison Table

Receptor GHRHR GHS-R1a Mechanism Gs/cAMP Gq/PKC/Ca²⁺ Half-life (rat) ~2 hours ~30-40 min GH Pattern Pulsatile Sustained Moderate DPP-IV Susceptible Resistant N/A FDA status Research Approved (specific indication) Table 3: Sermorelin vs. major GH secretagogue r

This comparison does not assign a generated winner or score.

  • Receptor
  • GHRHR
  • GHS-R1a
  • Mechanism
  • Gs/cAMP
  • Gq/PKC/Ca²⁺
  • Half-life (rat)
  • ~2 hours
  • ~30-40 min
  • GH Pattern
  • Pulsatile
  • Sustained
  • Moderate
  • DPP-IV
  • Susceptible
  • Resistant
  • N/A
  • FDA status
  • Research
  • Approved (specific indication)
  • Table 3: Sermorelin vs. major GH secretagogue research analogs.
More references

Related material

Comparison

Route Comparison Summary

Intravenous (IV) 100% Immediate PK studies, acute GH response studies Subcutaneous (SC) ~40-70% 5-10 minutes Standard animal model studies Intranasal Low Variable Delivery route c…

View details →